Invention Grant
- Patent Title: Sustained release formulation of nalbuphine
- Patent Title (中): 纳布啡的缓释制剂
-
Application No.: US13773136Application Date: 2013-02-21
-
Publication No.: US08765175B2Publication Date: 2014-07-01
- Inventor: Anand R. Baichwal , Philip A. Goliber , Anthony E. Carpanzano , Thomas Sciascia , Donald Diehl, II , Brian Vogler , David Verbel , Stanley Au
- Applicant: Penwest Pharmaceuticals Co.
- Applicant Address: US PA Malvern
- Assignee: Endo Pharmaceuticals Inc
- Current Assignee: Endo Pharmaceuticals Inc
- Current Assignee Address: US PA Malvern
- Agency: Davidson, Davidson & Kappel, LLC
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A01N43/42 ; A61K31/44
Abstract:
Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
Public/Granted literature
- US20130164350A1 SUSTAINED RELEASE FORMULATION OF NALBUPHINE Public/Granted day:2013-06-27
Information query
